1. Home
  2. BMRN vs COKE Comparison

BMRN vs COKE Comparison

Compare BMRN & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$53.40

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Logo Coca-Cola Consolidated Inc.

COKE

Coca-Cola Consolidated Inc.

HOLD

Current Price

$167.97

Market Cap

10.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMRN
COKE
Founded
1996
1902
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
10.0B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
BMRN
COKE
Price
$53.40
$167.97
Analyst Decision
Buy
Analyst Count
19
0
Target Price
$88.42
N/A
AVG Volume (30 Days)
3.0M
507.2K
Earning Date
10-27-2025
10-29-2025
Dividend Yield
N/A
0.59%
EPS Growth
59.53
22.14
EPS
2.68
7.03
Revenue
$3,094,001,000.00
$7,070,308,000.00
Revenue This Year
$13.39
N/A
Revenue Next Year
$7.57
N/A
P/E Ratio
$19.92
$23.91
Revenue Growth
12.39
4.22
52 Week Low
$50.76
$105.21
52 Week High
$73.51
$168.21

Technical Indicators

Market Signals
Indicator
BMRN
COKE
Relative Strength Index (RSI) 46.19 81.43
Support Level $53.03 $160.59
Resistance Level $54.66 $165.06
Average True Range (ATR) 1.45 3.33
MACD -0.11 -0.54
Stochastic Oscillator 31.61 97.79

Price Performance

Historical Comparison
BMRN
COKE

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About COKE Coca-Cola Consolidated Inc.

Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.

Share on Social Networks: